NO911861L - Stabilisert fgf-sammensetning. - Google Patents
Stabilisert fgf-sammensetning.Info
- Publication number
- NO911861L NO911861L NO91911861A NO911861A NO911861L NO 911861 L NO911861 L NO 911861L NO 91911861 A NO91911861 A NO 91911861A NO 911861 A NO911861 A NO 911861A NO 911861 L NO911861 L NO 911861L
- Authority
- NO
- Norway
- Prior art keywords
- fgf
- sos
- methods
- treatment
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 102000018233 Fibroblast Growth Factor Human genes 0.000 abstract 6
- 108050007372 Fibroblast Growth Factor Proteins 0.000 abstract 6
- 229940126864 fibroblast growth factor Drugs 0.000 abstract 6
- WEPNHBQBLCNOBB-FZJVNAOYSA-N sucrose octasulfate Chemical compound OS(=O)(=O)O[C@@H]1[C@H](OS(O)(=O)=O)[C@H](COS(=O)(=O)O)O[C@]1(COS(O)(=O)=O)O[C@@H]1[C@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H](COS(O)(=O)=O)O1 WEPNHBQBLCNOBB-FZJVNAOYSA-N 0.000 abstract 6
- 238000000034 method Methods 0.000 abstract 3
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- 230000000536 complexating effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 159000000001 potassium salts Chemical class 0.000 abstract 1
- 230000002797 proteolythic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 abstract 1
- 229960004291 sucralfate Drugs 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/524,144 US5202311A (en) | 1988-08-19 | 1990-05-15 | Stabilized fgf composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO911861D0 NO911861D0 (no) | 1991-05-14 |
| NO911861L true NO911861L (no) | 1991-11-18 |
Family
ID=24087954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91911861A NO911861L (no) | 1990-05-15 | 1991-05-14 | Stabilisert fgf-sammensetning. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5202311A (zh) |
| EP (1) | EP0457223A1 (zh) |
| JP (1) | JPH04330017A (zh) |
| KR (1) | KR910019637A (zh) |
| CN (1) | CN1058149A (zh) |
| AU (1) | AU637904B2 (zh) |
| CA (1) | CA2042569A1 (zh) |
| FI (1) | FI912348A (zh) |
| HU (1) | HU208635B (zh) |
| IE (1) | IE911655A1 (zh) |
| IL (1) | IL98040A0 (zh) |
| NO (1) | NO911861L (zh) |
| RU (1) | RU2070722C1 (zh) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260071A (en) * | 1989-12-18 | 1993-11-09 | Lemelson Jerome H | Drug units and methods for using same |
| US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
| US5482929A (en) * | 1991-12-26 | 1996-01-09 | Kaken Pharmaceutical Co., Ltd. | Composition of stabilized fibroblast growth factor |
| AU6794194A (en) * | 1993-05-18 | 1994-12-20 | Bukh Meditec A/S | A method for the preparation of interferons |
| JP3639593B2 (ja) | 1993-05-31 | 2005-04-20 | 科研製薬株式会社 | 塩基性線維芽細胞増殖因子含有架橋ゼラチンゲル製剤 |
| US5783568A (en) * | 1994-06-10 | 1998-07-21 | Sugen, Inc. | Methods for treating cancer and other cell proliferative diseases |
| JP3263598B2 (ja) * | 1995-11-01 | 2002-03-04 | 有限会社ドット | 経鼻吸収用生理活性ペプチド組成物 |
| AU729086C (en) * | 1996-03-05 | 2006-12-14 | Depuy Acromed, Inc. | Method of promoting bone growth with hyaluronic acid and growth factors |
| US20110207666A1 (en) * | 1996-03-05 | 2011-08-25 | Depuy Spine, Inc. | Method of promoting bone growth with hyaluronic acid and growth factors |
| US6221854B1 (en) * | 1996-03-05 | 2001-04-24 | Orquest, Inc. | Method of promoting bone growth with hyaluronic acid and growth factors |
| US6645945B1 (en) | 1996-03-05 | 2003-11-11 | Depuy Acromed, Inc. | Method of treating diseased, injured or abnormal cartilage with hyaluronic acid and growth factors |
| US7598224B2 (en) | 2002-08-20 | 2009-10-06 | Biosurface Engineering Technologies, Inc. | Dual chain synthetic heparin-binding growth factor analogs |
| US8227411B2 (en) | 2002-08-20 | 2012-07-24 | BioSurface Engineering Technologies, Incle | FGF growth factor analogs |
| US20080227696A1 (en) * | 2005-02-22 | 2008-09-18 | Biosurface Engineering Technologies, Inc. | Single branch heparin-binding growth factor analogs |
| WO2005082005A2 (en) * | 2004-02-20 | 2005-09-09 | Biosurface Engineering Technologies, Inc., Et Al. | Positive modulator of bone morphogenic protein-2 |
| EP2046350A4 (en) | 2006-06-22 | 2011-09-14 | Biosurface Eng Tech Inc | COMPOSITIONS AND METHOD FOR THE RELEASE OF A BMP-2 AMPLIFIER / COACTIVATOR FOR REINFORCED OSTEOGENESIS |
| GB0622688D0 (en) | 2006-11-14 | 2006-12-27 | Diosamine Dev Corp | Novel compounds |
| AU2007234612B2 (en) * | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
| US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
| WO2009020744A1 (en) | 2007-08-07 | 2009-02-12 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations comprising gdf-5 in aqueous acidic solution |
| AU2009236459B2 (en) * | 2008-04-14 | 2013-07-25 | Advanced Technologies And Regenerative Medicine, Llc | Liquid buffered GDF-5 formulations |
| US9347037B2 (en) * | 2013-02-11 | 2016-05-24 | Evan Masataka Masutani | Methods and apparatus for building complex 3D scaffolds and biomimetic scaffolds built therefrom |
| BR112018010676A2 (pt) | 2015-11-27 | 2019-04-09 | Enantis S.R.O. | polipeptídeo termoestável, uso e meio de cultura |
| US20220175885A1 (en) * | 2019-03-20 | 2022-06-09 | Reponex Pharmaceuticals A/S | Targeting biological agents to mucosal defects of the gastrointestinal tract |
| EP4183796A1 (en) | 2021-11-19 | 2023-05-24 | Enantis s.r.o. | Thermostable fgf10 polypeptide or fragment thereof use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU607690B2 (en) * | 1985-12-24 | 1991-03-14 | Marion Laboratories, Inc. | Use of synthetic sulfated saccharides to enhance wound healing |
| US4912093A (en) * | 1986-10-01 | 1990-03-27 | Marion Laboratories, Inc. | Use of synthetic sulfated saccharides to enhance wound healing |
| DE3628829C1 (de) * | 1986-08-25 | 1988-02-11 | Pantelis Bozoglou | Naehmaschine zum Annaehen eines Gummibandes |
| DK505488D0 (da) * | 1987-12-21 | 1988-09-09 | Bar Shalom Daniel | Middel og anvendelse af samme |
| AU614137B2 (en) * | 1988-06-06 | 1991-08-22 | Takeda Chemical Industries Ltd. | Stabilized fgf composition and production thereof |
| US5100668A (en) * | 1988-06-14 | 1992-03-31 | Massachusetts Institute Of Technology | Controlled release systems containing heparin and growth factors |
| US5175147A (en) * | 1988-08-19 | 1992-12-29 | Takeda Chemical Industries, Ltd | Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
| DE3900198A1 (de) * | 1989-01-05 | 1990-07-12 | Merck Patent Gmbh | Topisch anwendbare pharmazeutische zubereitung |
| FR2644066B1 (fr) * | 1989-03-09 | 1994-05-13 | Therapeutiques Substitutives | Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques |
| CA2020654A1 (en) * | 1989-07-07 | 1991-01-08 | Yohko Akiyama | Stabilized fgf composition and production thereof |
-
1990
- 1990-05-15 US US07/524,144 patent/US5202311A/en not_active Expired - Fee Related
-
1991
- 1991-05-02 IL IL98040A patent/IL98040A0/xx unknown
- 1991-05-11 EP EP91107682A patent/EP0457223A1/en not_active Withdrawn
- 1991-05-14 FI FI912348A patent/FI912348A/fi not_active Application Discontinuation
- 1991-05-14 CN CN91103961A patent/CN1058149A/zh active Pending
- 1991-05-14 IE IE165591A patent/IE911655A1/en unknown
- 1991-05-14 AU AU77030/91A patent/AU637904B2/en not_active Ceased
- 1991-05-14 HU HU911613A patent/HU208635B/hu not_active IP Right Cessation
- 1991-05-14 CA CA002042569A patent/CA2042569A1/en not_active Abandoned
- 1991-05-14 RU SU914895442A patent/RU2070722C1/ru active
- 1991-05-14 NO NO91911861A patent/NO911861L/no unknown
- 1991-05-15 KR KR1019910007897A patent/KR910019637A/ko not_active Application Discontinuation
- 1991-05-15 JP JP3110430A patent/JPH04330017A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU637904B2 (en) | 1993-06-10 |
| AU7703091A (en) | 1991-11-21 |
| KR910019637A (ko) | 1991-12-19 |
| IL98040A0 (en) | 1992-06-21 |
| CA2042569A1 (en) | 1991-11-16 |
| US5202311A (en) | 1993-04-13 |
| HU208635B (en) | 1993-12-28 |
| FI912348A0 (fi) | 1991-05-14 |
| EP0457223A1 (en) | 1991-11-21 |
| CN1058149A (zh) | 1992-01-29 |
| RU2070722C1 (ru) | 1996-12-20 |
| NO911861D0 (no) | 1991-05-14 |
| IE911655A1 (en) | 1991-11-20 |
| JPH04330017A (ja) | 1992-11-18 |
| FI912348A (fi) | 1991-11-16 |
| HUT57061A (en) | 1991-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO911861L (no) | Stabilisert fgf-sammensetning. | |
| JPS6429362A (en) | 3-demethylmevalonic acid derivative | |
| DK103384D0 (da) | Quinoloncarboxylsyrer eller salte eller hydrater deraf, deres fremstilling og anvendelse som antibakterielle midler | |
| ATE100093T1 (de) | Zweiwertige metallsalze von 2-n,ndi(carboxymethyl)amino,3-cyano,4-carboxymethyl, - carboxy-thiophensaeure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DK127986A (da) | Citronsyreestere eller salt deraf, fremgangsmaade til fremstilling deraf og anvendelse af saadanne forbindelser som overfladeaktive midler | |
| AU555971B2 (en) | Stable oral compositions containing zinc and fluoride compounds | |
| AU578783B2 (en) | Pyridopyrimidines, several processes for their preparation and their use as medicaments | |
| DK72289D0 (da) | Cephemcarboxylsyreestere, deres fremstilling og anvendelse | |
| AU1300383A (en) | Amides useful in the treatment of diabetes | |
| FI884195A (fi) | Olennaisesti puhdasta kalsiummagnesiumasetaattikaksoissuolaa sisältäviä jäänpoistokoostumuksia sekä menetelmiä niiden valmistamiseksi | |
| EP0331092A3 (en) | Alpha-amino-carboxylic-acid derivatives, their preparation and use | |
| DK0402806T3 (da) | Krystallinske cephem-syreadditionssalte og fremgangsmåde til fremstilling heraf | |
| DK568486D0 (da) | Primicinholdig, kolloidal, basisk gel, dens fremstilling og anvendelse i antibakterielle praeparater samt praeparaternes fremstilling | |
| DK597786A (da) | Krystallinske salte af aryloxypropanolaminer og fremgangsmaade til fremstilling heraf | |
| DE3361628D1 (en) | Substituted 5-phenylthio-6-amino-pyrimidinones, process for their preparation and their use, and preparations containing these compounds | |
| ES541916A0 (es) | Procedimiento para el tratamiento de disoluciones acidas de uranio por adicion de una sal de aluminio | |
| AU562643B2 (en) | N-arylpiperazine derivatives | |
| JPS57130545A (en) | Urea adsorbing agent | |
| YU47096B (sh) | Antivirusna jedinjenja i postupak za njihovo dobijanje | |
| AU3931389A (en) | Aminocarbonyl-substituted pyridinesulfinic acid or salts thereof | |
| DK180086D0 (da) | 12b-substituerede 1-hydroxymethyl-octahydroindolo(2,3-a)-quinolizinderivater eller isomere eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika | |
| DK420187D0 (da) | Oxiran-pseudooligosaccharider, deres fremstilling og anvendelse | |
| IT8619750A0 (it) | Procedimento per la preparazione di flucloxacillina sale sodico per uso orale e inittabile. | |
| AU8870791A (en) | Use of temocillin or carbenicillin for the treatment or prophylaxis of bacterial infections in fish | |
| FI930300A (fi) | 5-Amino-1,2,4-tiadiatsol-3-yyli-iminokarbonyyliyhdiste |